Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Hemorrhage and Thrombosis in Hematology Malignancies: Understanding the Risks of Thrombosis and Anticoagulation in Patients With Hematologic Malignancies (HAT Trial)

NCT05053100 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

NCT NCT05053100
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05053100 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Hemorrhage and Thrombosis in Hematology Malignancies: Understanding the Risks of Thrombosis and Anticoagulation in Patients With Hematologic Malignancies (HAT Trial)
Lead sponsor
Mayo Clinic
Phase
Observational
Overall status
Completed
Start date
August 17, 2021
Completion date
July 5, 2024
Enrollment
100 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute leukemia, deep vein thrombosis, hematopoietic and lymphoid cell neoplasm, hodgkin lymphoma, myeloproliferative neoplasm, non-hodgkin lymphoma, plasma cell myeloma, thrombocytopenia